(Q33158326)

23 July 2017

1 reference

title

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers (English)

1 reference

hypertrophic cardiomyopathy

23 July 2017

1 reference

1 reference

7

Arthur A M Wilde

1 reference

23 July 2017

Imke Christiaans

1

1 reference

23 July 2017

Klaartje van Engelen

2

1 reference

23 July 2017

Irene M van Langen

3

1 reference

23 July 2017

Erwin Birnie

4

1 reference

23 July 2017

Gouke J Bonsel

5

1 reference

23 July 2017

Perry M Elliott

6

1 reference

23 July 2017

publication date

29 January 2010

1 reference

23 July 2017

1 reference

23 July 2017

volume

12

1 reference

23 July 2017

issue

3

1 reference

23 July 2017

page(s)

313-321

1 reference

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Prognosis in hypertrophic cardiomyopathy observed in a large clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Electrocardiographic findings in patients with hypertrophic cardiomyopathy. Relation to presenting features and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Predictors of sudden cardiac death in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Natural history of hypertrophic cardiomyopathy in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

New concepts in hypertrophic cardiomyopathies, part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

A new missense mutation, Arg719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Clinical Features of Hypertrophic Cardiomyopathy Caused by Mutation of a “Hot Spot” in the Alpha-Tropomyosin Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

The Val606Met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Epidemiology of Hypertrophic Cardiomyopathy–Related Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Genotype–phenotype correlations in familial hypertrophic cardiomyopathy A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

Homozygotes for a R869G Mutation in the β -myosin Heavy Chain Gene have a Severe Form of Familial Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP431

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUP431

1 reference

23 July 2017

1 reference